More Chinese drugmakers are moving beyond GLP-1s, adopting new strategies to capture a larger share of the global diabetes market.

longevity.technology/news/more-ch...

#DiabetesInnovation #ChineseBiotech #GLP1Alternatives #Healthspan #longevity #PrecisionMedicine #MetabolicHealth #BiotechTrends